Medicine

Judy O’Donnell, the associate chief medical officer for Healthcare Epidemiology for the University of Pennsylvania Health System, and the chief of Infectious Diseases at Penn Presbyterian Medical Center, explains what people need to know about measles.

New research from Penn Medicine reveals a safe delivery system of DNA-loaded lipid nanoparticles directly to cells, which could transform treatment for common chronic diseases like heart disease, diabetes, and cancer.

Professors from the School of Arts & Sciences, Perelman School of Medicine, and School of Engineering and Applied Science are among 471 scientists, engineers, and innovators being recognized by the American Association for the Advancement of Science.

At Penn’s annual Women in STEM Symposium, Vanessa Chan, Allyson Mackey, Ping Wang, and Melissa Kelly shared lessons from their experiences.

Ko, a professor in bioengineering in Penn Engineering and in Pathology and Laboratory Medicine in the Perelman School of Medicine, is awarded the 2025 National Science Foundation (NSF) CAREER Award for her expertise across bioengineering, molecular biology, and chemistry in developing transformative technologies for molecular diagnostics of diseases, especially with respect to how brain-related conditions are diagnosed and treated.

A preclinical study from the Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center that combines RAS inhibition and immunotherapy shows promise for future clinical trials in pancreatic cancer treatment strategies.

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently recommended six months—can more than double weight loss for patients who struggle initially with lifestyle changes alone, according to new research published in Nature Medicine from a team at the Perelman School of Medicine.

Griffo has worked at Penn for nearly two decades, serving most recently as Chief Advancement Officer for Penn Medicine Development and Alumni Relations.